The Market Doesn't Like What It Sees From Tianda Pharmaceuticals Limited's (HKG:455) Revenues Yet
May 28
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedJun 01, 2025
DataAggregated Company Financials
Companies40
- 7D6.2%
- 3M36.5%
- 1Y34.8%
- YTD41.4%
The Pharma industry is up 6.2% in the last week, with CSPC Pharmaceutical Group up 22%. Meanwhile, Grand Pharmaceutical Group actually underperformed within the industry, shrinking 6.0% in the last week. In the last 12 months, the industry was up 35%. Earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 02 Jun 2025 | HK$597.0b | HK$475.0b | HK$28.7b | 10.9x | 20.8x | 1.3x |
| Wed, 30 Apr 2025 | HK$503.6b | HK$467.9b | HK$28.7b | 10.4x | 17.6x | 1.1x |
| Fri, 28 Mar 2025 | HK$466.0b | HK$473.1b | HK$32.1b | 9.4x | 14.5x | 1x |
| Sun, 23 Feb 2025 | HK$455.5b | HK$463.1b | HK$31.9b | 8.7x | 14.3x | 1x |
| Tue, 21 Jan 2025 | HK$403.8b | HK$460.1b | HK$31.7b | 8x | 12.7x | 0.9x |
| Thu, 19 Dec 2024 | HK$436.9b | HK$461.1b | HK$31.8b | 8.4x | 13.7x | 0.9x |
| Sat, 16 Nov 2024 | HK$432.8b | HK$465.3b | HK$32.3b | 8.2x | 13.4x | 0.9x |
| Mon, 14 Oct 2024 | HK$512.8b | HK$474.4b | HK$32.9b | 7.9x | 15.6x | 1.1x |
| Wed, 11 Sep 2024 | HK$423.5b | HK$472.6b | HK$32.8b | 7.8x | 12.9x | 0.9x |
| Fri, 09 Aug 2024 | HK$440.9b | HK$462.7b | HK$32.8b | 7.4x | 13.4x | 1x |
| Sun, 07 Jul 2024 | HK$445.9b | HK$461.5b | HK$33.7b | 7.9x | 13.2x | 1x |
| Tue, 04 Jun 2024 | HK$460.3b | HK$464.2b | HK$33.9b | 8.3x | 13.6x | 1x |
| Thu, 02 May 2024 | HK$458.2b | HK$463.6b | HK$33.8b | 7.5x | 13.6x | 1x |
| Sat, 30 Mar 2024 | HK$446.0b | HK$465.8b | HK$36.6b | 7.7x | 12.2x | 1x |
| Mon, 26 Feb 2024 | HK$447.7b | HK$470.7b | HK$33.5b | 7.8x | 13.4x | 1x |
| Wed, 24 Jan 2024 | HK$412.2b | HK$472.0b | HK$33.7b | 6.7x | 12.2x | 0.9x |
| Fri, 22 Dec 2023 | HK$459.8b | HK$472.4b | HK$33.8b | 7.4x | 13.6x | 1x |
| Sun, 19 Nov 2023 | HK$502.3b | HK$470.8b | HK$32.1b | 7x | 15.6x | 1.1x |
| Tue, 17 Oct 2023 | HK$442.5b | HK$469.3b | HK$31.5b | 7.2x | 14x | 0.9x |
| Thu, 14 Sep 2023 | HK$424.8b | HK$470.2b | HK$31.7b | 6.7x | 13.4x | 0.9x |
| Sat, 12 Aug 2023 | HK$440.0b | HK$446.6b | HK$28.2b | 8.6x | 15.6x | 1x |
| Mon, 10 Jul 2023 | HK$477.0b | HK$445.8b | HK$27.8b | 9.4x | 17.2x | 1.1x |
| Wed, 07 Jun 2023 | HK$511.3b | HK$448.5b | HK$27.9b | 8.5x | 18.3x | 1.1x |
| Fri, 05 May 2023 | HK$573.9b | HK$453.4b | HK$28.5b | 9.1x | 20.2x | 1.3x |
| Sun, 02 Apr 2023 | HK$539.3b | HK$453.2b | HK$28.9b | 9.4x | 18.7x | 1.2x |
| Tue, 28 Feb 2023 | HK$591.4b | HK$443.5b | HK$35.0b | 11.9x | 16.9x | 1.3x |
| Thu, 26 Jan 2023 | HK$635.9b | HK$447.3b | HK$35.6b | 10.7x | 17.9x | 1.4x |
| Sat, 24 Dec 2022 | HK$585.2b | HK$441.7b | HK$34.7b | 10.6x | 16.9x | 1.3x |
| Mon, 21 Nov 2022 | HK$617.2b | HK$437.7b | HK$34.0b | 9.5x | 18.1x | 1.4x |
| Wed, 19 Oct 2022 | HK$573.7b | HK$513.3b | HK$38.9b | 8.7x | 14.7x | 1.1x |
| Fri, 16 Sep 2022 | HK$537.7b | HK$519.6b | HK$40.7b | 9.2x | 13.2x | 1x |
| Sun, 14 Aug 2022 | HK$587.7b | HK$513.4b | HK$51.4b | 8x | 11.4x | 1.1x |
| Tue, 12 Jul 2022 | HK$654.1b | HK$515.0b | HK$52.3b | 8.9x | 12.5x | 1.3x |
| Thu, 09 Jun 2022 | HK$574.0b | HK$516.2b | HK$52.2b | 9.2x | 11x | 1.1x |
Price to Earnings Ratio
11x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 20.8x which is higher than its 3-year average PE of 14.8x.
- The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 18% per year over the last three years,
- Revenues have also declined 2.7% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | -0.59% | |
| Healthcare | 4.11% | |
| Pharma | 6.25% | |
| Pharma | 6.25% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1093 CSPC Pharmaceutical Group | HK$8.10 | 22.4% +HK$16.9b | 22.2% | PE20.3x | |
| 2096 Simcere Pharmaceutical Group | HK$12.84 | 24.2% +HK$6.2b | 119.1% | PE39.8x | |
| 1177 Sino Biopharmaceutical | HK$4.45 | 6.5% +HK$4.8b | 56.7% | PE38.1x | |
| 3933 United Laboratories International Holdings | HK$14.62 | 8.9% +HK$2.2b | 62.4% | PE9.2x | |
| 3692 Hansoh Pharmaceutical Group | HK$25.85 | 0.8% +HK$1.2b | 61.0% | PE32.3x |
